Methotrexate-related lymphoproliferative disease
Methotrexate-associated lymphoproliferative disease refers to individuals (patients with autoimmune diseases such as rheumatoid arthritis, psoriasis, and dermatomyositis) who have long-term application of the immunosuppressant methotrexate (MTX) Lymphatic tissue proliferation or lymphoma.
The material in this site is intended to be of general informational use and is not intended to constitute medical advice, probable diagnosis, or recommended treatments.